Suzhou Novoprotein Correlations

688137 Stock   34.37  0.72  2.05%   
The current 90-days correlation between Suzhou Novoprotein and Anshan Senyuan Road is -0.08 (i.e., Good diversification). The correlation of Suzhou Novoprotein is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Suzhou Novoprotein Correlation With Market

Significant diversification

The correlation between Suzhou Novoprotein Scientific and DJI is 0.06 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Suzhou Novoprotein Scientific and DJI in the same portfolio, assuming nothing else is changed.
  
The ability to find closely correlated positions to Suzhou Novoprotein could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Suzhou Novoprotein when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Suzhou Novoprotein - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Suzhou Novoprotein Scientific to buy it.

Moving together with Suzhou Stock

  0.62600519 Kweichow MoutaiPairCorr
  0.63600036 China Merchants BankPairCorr
  0.77002594 BYD CoPairCorr

Moving against Suzhou Stock

  0.65601857 PetroChinaPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
000917688432
002307688432
300210000917
300223002307
300210688432
002249688432
  
High negative correlations   
688249002249
688981688432
688981002249

Risk-Adjusted Indicators

There is a big difference between Suzhou Stock performing well and Suzhou Novoprotein Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Suzhou Novoprotein's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Suzhou Novoprotein without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Volatility Now

   

Portfolio Volatility

Check portfolio volatility and analyze historical return density to properly model market risk
All  Next Launch Module

Suzhou Novoprotein Corporate Executives

Elected by the shareholders, the Suzhou Novoprotein's board of directors comprises two types of representatives: Suzhou Novoprotein inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Suzhou. The board's role is to monitor Suzhou Novoprotein's management team and ensure that shareholders' interests are well served. Suzhou Novoprotein's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Suzhou Novoprotein's outside directors are responsible for providing unbiased perspectives on the board's policies.
Dongye ZhangAccounting CFOProfile